The German pharmaceutical company "Bayer" confirmed today, Wednesday, that "initial tests on humans (over a year) have shown that the experimental stem cell treatment for Parkinson's disease has been well tolerated by patients, and the implanted cells remain alive in their brains." In a notable move, "Blue Rock Therapeutics" encouraged the development of the treatment testing on humans and its transition to the second phase out of three.
Positive Results for Experimental Parkinson's Treatment
Share
